Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 years or older
- People who have been diagnosed with metastatic breast cancer that is HER2-positive (a type of breast cancer that has spread and has a specific protein that affects cancer growth)
- People whose treatment with tucatinib, trastuzumab, and capecitabine (a specific combination of cancer medicines) is approved and covered under the local guidelines and reimbursement rules in their country
- People who have already received at least 2 previous treatments targeting HER2, at any stage of their care
- People who have given written consent showing they understand the study's purpose and procedures and agree to take part
Who may not be able to join:
- People who have other diseases or significant health conditions that, in the investigator's opinion, could affect how the study results are measured
- People who have not had any imaging or scanning assessments (such as CT or MRI scans) carried out (confirm with trial site)
- People for whom there is no recorded information about how tucatinib has worked or what side effects it caused (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 08117770442
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess the treatment safety and effectiveness as measured by investigator criteria in metastatic breast cancer patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.